Request Demo
Last update 29 Nov 2025
GDC-7035
Last update 29 Nov 2025
Overview
Basic Info
Drug Type Unknown |
Synonyms GDC-7035, RG6620 |
Target |
Action inhibitors |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with GDC-7035NCT06619587
A Phase I/II Dose-Escalation and Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors With a KRAS G12D Mutation
CTIS2024-515144-23-00
A Phase I/II Dose-Escalation and Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination with Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors With a KRAS G12D Mutation - GO45416
100 Clinical Results associated with GDC-7035
Login to view more data
100 Translational Medicine associated with GDC-7035
Login to view more data
100 Patents (Medical) associated with GDC-7035
Login to view more data
100 Deals associated with GDC-7035
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | United States | 14 Nov 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Australia | 14 Nov 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Canada | 14 Nov 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Israel | 14 Nov 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Singapore | 14 Nov 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | South Korea | 14 Nov 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Spain | 14 Nov 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | United Kingdom | 14 Nov 2024 | |
| Metastatic Solid Tumor | Phase 1 | United States | 14 Nov 2024 | |
| Metastatic Solid Tumor | Phase 1 | Australia | 14 Nov 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free